<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="805">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05150678</url>
  </required_header>
  <id_info>
    <org_study_id>obstetric and gynacology</org_study_id>
    <nct_id>NCT05150678</nct_id>
  </id_info>
  <brief_title>Removal Versus Non Removal of Ceserean Section Scar .</brief_title>
  <acronym>cs</acronym>
  <official_title>EXCISION of CAESAREAN SECTION SKIN SCAR AND SUBCUTANEOUS RELEASE VERSUS NON REMOVAL IN REPEATED CAESAREAN SECTION.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      EXCISION of cs section skin scar and subcutaneous release versus non removal in repeated cs&#xD;
      .aRandomized controlled trial .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All eligible participants will randimized into two groups ; gruop 1 skin removal in which we&#xD;
      will going to remove skin scar gruop 2 skin non removal ;direct open in the middle of the&#xD;
      previous scar Follow up will be recorded for each participant aphoto will be taken&#xD;
      postoperative to score the healing of the wound the follow up will be at one week ,then one&#xD;
      month ,then three month acomparison between the two groups will be done .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>there are two gruops in the study ;one with removal of the scar 2nd with non removal in repeated cs</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the healing score</measure>
    <time_frame>through the study duration AVERAGE ONE YEAR.</time_frame>
    <description>we will follow up the scar postoperative to compare the healing score by observer scar assessment scale maximaum score 5and patient scar assessment scale.maximum score 10.means WORST scale .</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the cosmotic appereance of the scar</measure>
    <time_frame>through the study duration an average one year</time_frame>
    <description>we will follow up the scar healing postoperative by the observer scale assessment score and the patient scar assessment scale .</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Removal of Previous Ceserean Section Scar and Subcutanus Release</condition>
  <condition>Non Removal of Previous Ceserean Section Scar and Subcutaneous Release</condition>
  <arm_group>
    <arm_group_label>removal of cs scar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>gruop 1 will remove the scar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non removal of the scar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>gruop2 will not remove the scar</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>removal of ceserean section scar</intervention_name>
    <description>we will remove the previous scar in group A</description>
    <arm_group_label>non removal of the scar</arm_group_label>
    <arm_group_label>removal of cs scar</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>non removal of cesearean section scar</intervention_name>
    <description>we will open in the previous cesearean scar in group B</description>
    <arm_group_label>non removal of the scar</arm_group_label>
    <arm_group_label>removal of cs scar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. women with repeated ceserean section&#xD;
&#xD;
          2. pregnant women &gt;32 wk&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  DM bleeding tendency preeclampsia previous history of wound infection chronic steroid&#xD;
             use women refused to participate in Randomized clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Altman AD, Allen VM, McNeil SA, Dempster J. Pfannenstiel incision closure: a review of current skin closure techniques. J Obstet Gynaecol Can. 2009 Jun;31(6):514-520. doi: 10.1016/S1701-2163(16)34213-X. Review.</citation>
    <PMID>19646316</PMID>
  </reference>
  <reference>
    <citation>Kawakita T, Landy HJ. Surgical site infections after cesarean delivery: epidemiology, prevention and treatment. Matern Health Neonatol Perinatol. 2017 Jul 5;3:12. doi: 10.1186/s40748-017-0051-3. eCollection 2017. Review.</citation>
    <PMID>28690864</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 17, 2021</study_first_submitted>
  <study_first_submitted_qc>November 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>November 26, 2021</last_update_submitted>
  <last_update_submitted_qc>November 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>mayada aboelmagd mohamed</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

